NEW YORK (GenomeWeb News) – Scientists at the Whitehead Institute will use $5.3 million over the next three years from Biogen Idec to pursue research projects involving genomics, genetics, immunology, neurology, developmental biology, and other approaches.

Under a new research collaboration agreement, the funding from the Weston, Mass.-based drug developer will support early stage research projects addressing a wide array of disease areas, the Whitehead Institute said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.